ContextVision AB | Cash Flow

Fiscal year is January-December. All values NOK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,724.50
6,453.90
6,651.90
5,657.00
1,914.00
1,207.70
Depreciation, Depletion & Amortization
3,198.00
3,527.70
4,076.10
6,045.50
4,720.20
4,704.50
Other Funds
407.10
778.80
1,119.50
1,395.90
2,503.30
2,195.50
Funds from Operations
8,515.40
9,202.80
9,608.40
10,306.70
302.90
5,692.30
Changes in Working Capital
1,598.60
324.20
847.70
962.30
1,582.10
903.70
Net Operating Cash Flow
6,916.80
9,527.00
8,760.70
9,344.40
1,885.00
4,788.70
Capital Expenditures
2,905.60
7,862.80
5,145.80
2,149.20
4,385.40
Net Investing Cash Flow
2,905.60
7,717.70
4,446.40
2,216.90
4,385.40
Net Change in Cash
4,011.30
1,809.30
4,314.30
7,127.50
2,500.40
Free Cash Flow
6,895.20
9,039.30
8,656.40
9,133.50
1,496.00
Other Sources
-
145.10
699.40
-
-
Other Uses
-
-
-
67.70
-

About ContextVision AB

View Profile
Address
Klara Norra Kyrkogata 31
Stockholm AB 111 22
Sweden
Employees -
Website http://www.contextvision.com
Updated 07/08/2019
ContextVision AB engages in the development of image enhancement software for medical industry. Its products include ultrasound devices under US PLUSView, GOPiCE, REALiCE, and VolarView brands; and radiography, magnetic resonance imaging, and mammography under GOPView brand. The company was founded by Sven Gunther-Hanssen and Martin Hedlund in 1983 and is headquartered in Stockholm, Sweden.